Filing Flows › Microbot Medical (MBOT) › Q2 2026
Microbot Medical (MBOT) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 11, 2026
Microbot Medical (MBOT) reported revenue of $241K for the second quarter 2026 (Q2 2026) and +130% from the quarter before.
Microbot Medical, Q2 2026: revenue $241K, net loss $5.6M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $241K | +130% | — |
| Operating profit | −$6.2M | — | — |
| Net earnings | −$5.6M | — | — |
| Operating cash flow | −$5.0M | — | — |
What changed
Revenue was $241K in Q2 2026, up 130% from the previous quarter.
Operating costs exceeded revenue by $6.2M, an operating margin of -2567.6%. The quarter ended with a net loss of $5.6M, wider than the previous quarter's $3.7M loss.
Operating cash flow was −$5.0M. Non-cash charges added back $15K of depreciation and amortization and $433K of share-based compensation. Capital expenditures of $142K exceeded it, leaving free cash flow of −$5.1M.
Questions
What was Microbot Medical's revenue in the second quarter 2026?
Microbot Medical (MBOT) reported revenue of $241K for the second quarter 2026 (Q2 2026) and +130% from the quarter before.
Source: Microbot Medical 10-Q on SEC EDGAR.